search
Unlocking New Possibilities in Bioconjugate Innovation. Connect with Our Experts at World ADC San Diego - Booth No 16.
Book a Meeting
For pharma innovators, bringing a new therapy to market requires more than scientific insight; it demands a strategic partnership with a CDMO that can support the full scope of development and manufacturing.
Nov 14, 2025
The development of high-potency active pharmaceutical ingredients (HPAPIs) and hormonal drugs represents one of the most demanding areas in modern pharmaceutical manufacturing.
Nov 05, 2025
In today's competitive pharmaceutical landscape, speed and precision are crucial for transforming promising concepts into viable drug candidates. Yet, the path from hit identification to optimized lead is often hindered by complex structure–activity relationship (SAR) studies, demanding synthesis requirements, and iterative cycles of testing and refinement.
Oct 31, 2025
Oral Solid Dosage (OSD) forms – such as tablets and capsules – remain the backbone of modern pharmaceuticals. They are stable, scalable, and preferred by patients for their convenience and ease of administration.
Oct 28, 2025
For decades, Contract Development and Manufacturing Organizations (CDMOs) have been valued primarily for their expertise in chemistry and processes, alongside specialized skills in scale-up, synthesis, and compliance. But as the pharmaceutical landscape becomes increasingly complex and patient-centered, the expectations placed on CDMOs are rapidly evolving.
Oct 24, 2025
